These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32209869)

  • 1. Severe Adult Atopic Dermatitis: Clinical Challenges.
    Russo F; Flori ML; Gola M; Milanesi N
    Dermatitis; 2020; 31(4):e48-e49. PubMed ID: 32209869
    [No Abstract]   [Full Text] [Related]  

  • 2. EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers.
    Bakker DS; Ariens LFM; Giovannone B; Hijnen D; Delemarre EM; Knol E; Nierkens S; de Bruin-Weller MS; Thijs JL; Drylewicz J
    Allergy; 2020 Dec; 75(12):3287-3289. PubMed ID: 33305359
    [No Abstract]   [Full Text] [Related]  

  • 3. Two Cancer Patients Receiving Dupilumab for Treatment of Atopic Dermatitis.
    Fowler E; Rosen J; Lev-Tov H; Yosipovitch G
    Acta Derm Venereol; 2019 Sep; 99(10):899-900. PubMed ID: 31037315
    [No Abstract]   [Full Text] [Related]  

  • 4. Dupilumab (Dupixent) for moderate to severe atopic dermatitis.
    Med Lett Drugs Ther; 2017 Apr; 59(1519):64-66. PubMed ID: 28419072
    [No Abstract]   [Full Text] [Related]  

  • 5. The beginning of biological treatment era in the atopic dermatitis management.
    D'erme AM
    Dermatol Ther; 2016 May; 29(3):208-9. PubMed ID: 26331894
    [No Abstract]   [Full Text] [Related]  

  • 6. Targeted Treatment of Atopic Dermatitis.
    Metin SA; Wallace M
    Skinmed; 2017; 15(2):137-138. PubMed ID: 28528610
    [No Abstract]   [Full Text] [Related]  

  • 7. Concurrent Atopic Dermatitis and Psoriasis Successfully Treated With Brodalumab.
    Gambardella A; Licata G; De Rosa A; Pagliuca F; Calabrese G; Alfano R; Argenziano G
    Dermatitis; 2021 Oct; 32(1S):e86-e88. PubMed ID: 33208631
    [No Abstract]   [Full Text] [Related]  

  • 8. Young HIV-positive male patient with severe atopic dermatitis on dupilumab and SARS-CoV-2 infection, a pioneer hypothesis.
    Ordóñez-Rubiano MF; Rubiano-Mojica PC; Casas M
    Int J Dermatol; 2021 Apr; 60(4):514-515. PubMed ID: 33644864
    [No Abstract]   [Full Text] [Related]  

  • 9. Alopecia Universalis and Atopic Dermatitis Improvement with Dupilumab: Demonstration of a Shared Pathophysiology and Clinical Efficacy.
    Dobkin H; Mullen R; Zirwas M
    Skinmed; 2019; 17(2):139-140. PubMed ID: 31145072
    [No Abstract]   [Full Text] [Related]  

  • 10. Dupilumab Versus Cyclosporine for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index.
    Ariëns LFM; Gadkari A; van Os-Medendorp H; Ayyagari R; Terasawa E; Kuznik A; Chen Z; Bégo-Le Bagousse G; Lu Y; Rizova E; Graham NMH; Pirozzi G; De Bruin-Weller M; Eckert L
    Acta Derm Venereol; 2019 Sep; 99(10):851-857. PubMed ID: 31099402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dupixent® (Dupilumab): A Newly Approved Interleukin-4 Receptor Antagonist for the Treatment of Atopic Dermatitis in Pediatric Patients.
    Gupta AK; Love RP; Abramovits W; Vincent KD
    Skinmed; 2019; 17(2):107-109. PubMed ID: 31145061
    [No Abstract]   [Full Text] [Related]  

  • 12. Gaining access to treatment; life at the far side of atopic eczema.
    Dolan M; Blake C; Cosgrave N; McMahon D; Greenwood M; Tobin AM
    Clin Exp Dermatol; 2022 Mar; 47(3):624-625. PubMed ID: 34862805
    [No Abstract]   [Full Text] [Related]  

  • 13. Allergic contact dermatitis to Compositae: A possible cause of dupilumab-associated facial and neck dermatitis in atopic dermatitis patients?
    Napolitano M; Fabbrocini G; Patruno C
    Contact Dermatitis; 2021 Oct; 85(4):473-474. PubMed ID: 33988858
    [No Abstract]   [Full Text] [Related]  

  • 14. Dupilumab: a revolutionary emerging drug in atopic dermatitis and its possible role in pemphigus.
    Tavakolpour S
    Dermatol Ther; 2016 Sep; 29(5):299. PubMed ID: 26800435
    [No Abstract]   [Full Text] [Related]  

  • 15. Monoclonal antibodies for the treatment of atopic dermatitis.
    Renert-Yuval Y; Guttman-Yassky E
    Curr Opin Allergy Clin Immunol; 2018 Aug; 18(4):356-364. PubMed ID: 29870461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Dupilumab in an Atopic Adolescent With Primary Immune Deficiency.
    Tanner JF; Knutsen AP; Siegfried E
    Dermatitis; 2021 Oct; 32(1S):e91-e92. PubMed ID: 34677168
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of dupilumab on atopic manifestations in patients treated for atopic dermatitis in real-life practice.
    Tauber M; Apoil PA; Richet C; Laurent J; De Bonnecaze G; Mouchon E; Cassagne M; Marguery MC; Hegazy S; Konstantinou MP; Severino M; Uthurriague C; Giordano-Labadie F; Didier A; Paul C
    Br J Dermatol; 2019 Jun; 180(6):1551-1552. PubMed ID: 30633329
    [No Abstract]   [Full Text] [Related]  

  • 18. Omalizumab for the treatment of atopic dermatitis.
    Fernández-Antón Martínez MC; Leis-Dosil V; Alfageme-Roldán F; Paravisini A; Sánchez-Ramón S; Suárez Fernández R
    Actas Dermosifiliogr; 2012 Sep; 103(7):624-8. PubMed ID: 22056257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dupilumab may facilitate the clearance of molluscum contagiosum in atopic dermatitis patients.
    Di Lernia V; Casanova DM; Simonetti V
    J Dtsch Dermatol Ges; 2020 Sep; 18(9):1016-1018. PubMed ID: 32881369
    [No Abstract]   [Full Text] [Related]  

  • 20. Remittive effect of Dupilumab in atopic dermatitis.
    Treister AD; Lio PA
    Dermatol Ther; 2018 Nov; 31(6):e12711. PubMed ID: 30253014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.